Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Greer

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Bone Marrow Transplantation|June 5, 2012
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markersS M Sengsayadeth, M Jagasia, B G Engelhardt, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignanciesMadan Jagasia, William B Clark, Kristin D Brown-Gentry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Cytotherapy|July 1, 2010
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantationSara K Tedeschi, Madan Jagasia, Brian G Engelhardt, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Bone Marrow Transplantation|June 5, 2012
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markersS M Sengsayadeth, M Jagasia, B G Engelhardt, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignanciesMadan Jagasia, William B Clark, Kristin D Brown-Gentry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|April 10, 2012
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteriaR Jacobs, U Tran, H Chen, et al.
Cytotherapy|July 1, 2010
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantationSara K Tedeschi, Madan Jagasia, Brian G Engelhardt, et al.
Pageof 18